CIAM
AURA icon

Caitong International Asset Management’s Aura Biosciences AURA Stock Holding History

Caitong International Asset Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$504 Buy
71
+69
+3,450% +$494 ﹤0.01% 1729
2026
Q1 		$13 Buy
+2
New +$11 ﹤0.01% 2111

Other funds holding AURA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
TGAM
TBH Global Asset Management Brentwood, Tennessee $546M AUM 26.68% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
NC
nVerses Capital Wellington, Florida $65M AUM
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Caitong International Asset Management's AURA Position: Q2 2026 in Review

Caitong International Asset Management increased its Aura Biosciences (AURA) stake by 3,450% in Q2 2026, buying an estimated $494 and bringing the position to 71 shares worth $504. The position accounts for ﹤0.01% of the portfolio, ranked #1729.

Caitong International Asset Management first reported a position in AURA in Q1 2026 and has held it in 2 quarters since. 34 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Caitong International Asset Management held 71 shares of Aura Biosciences worth $504 as of Q2 2026.
  • Caitong International Asset Management bought 69 Aura Biosciences shares in Q2 2026, an estimated $494.
  • Aura Biosciences made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1729 holding.
  • Caitong International Asset Management first reported a position in Aura Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 34 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.